658 related articles for article (PubMed ID: 25897797)
1. Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study.
Joa I; Gisselgård J; Brønnick K; McGlashan T; Johannessen JO
BMC Psychiatry; 2015 Apr; 15():89. PubMed ID: 25897797
[TBL] [Abstract][Full Text] [Related]
2. Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial.
Armando M; De Crescenzo F; Vicari S; Digilio MC; Pontillo M; Papaleo F; Amminger GP
Early Interv Psychiatry; 2016 Oct; 10(5):390-6. PubMed ID: 25345540
[TBL] [Abstract][Full Text] [Related]
3. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
4. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
[TBL] [Abstract][Full Text] [Related]
5. Intervention in individuals at ultra-high risk for psychosis: a review and future directions.
McGorry PD; Nelson B; Amminger GP; Bechdolf A; Francey SM; Berger G; Riecher-Rössler A; Klosterkötter J; Ruhrmann S; Schultze-Lutter F; Nordentoft M; Hickie I; McGuire P; Berk M; Chen EY; Keshavan MS; Yung AR
J Clin Psychiatry; 2009 Sep; 70(9):1206-12. PubMed ID: 19573499
[TBL] [Abstract][Full Text] [Related]
6. Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
[TBL] [Abstract][Full Text] [Related]
7. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
8. Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program.
Tso IF; Taylor SF; Grove TB; Niendam T; Adelsheim S; Auther A; Cornblatt B; Carter CS; Calkins R; Ragland JD; Sale T; McFarlane WR
Early Interv Psychiatry; 2017 Feb; 11(1):14-22. PubMed ID: 25529847
[TBL] [Abstract][Full Text] [Related]
9. [Early detection of psychotic disorders].
Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
[TBL] [Abstract][Full Text] [Related]
10. Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients.
Schultze-Lutter F; Rahman J; Ruhrmann S; Michel C; Schimmelmann BG; Maier W; Klosterkötter J
Soc Psychiatry Psychiatr Epidemiol; 2015 Dec; 50(12):1831-41. PubMed ID: 26155901
[TBL] [Abstract][Full Text] [Related]
11. Early Detection of Ultra High Risk for Psychosis in a Norwegian Catchment Area: The Two Year Follow-Up of the Prevention of Psychosis Study.
Joa I; Bjornestad J; Johannessen JO; Langeveld J; Stain HJ; Weibell M; Hegelstad WTV
Front Psychiatry; 2021; 12():573905. PubMed ID: 33716805
[No Abstract] [Full Text] [Related]
12. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Bechdolf A; Müller H; Stützer H; Wagner M; Maier W; Lautenschlager M; Heinz A; de Millas W; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Brüne M; Krüger-Özgürdal S; Wobrock T; Riedel M; Klosterkötter J;
Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S111-21. PubMed ID: 21860040
[TBL] [Abstract][Full Text] [Related]
13. Rationale for clinical interventions in prodromal psychosis. Are such interventions safe?
Agius M; Butler S
Psychiatr Danub; 2012 Sep; 24 Suppl 1():S28-35. PubMed ID: 22945183
[TBL] [Abstract][Full Text] [Related]
14. [Early detection and early intervention in first episode psychosis].
Bourgin J; Krebs MO
Rev Prat; 2013 Mar; 63(3):336-42. PubMed ID: 23687756
[TBL] [Abstract][Full Text] [Related]
15. Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.
Mees L; Zdanowicz N; Reynaert C; Jacques D
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S118-22. PubMed ID: 21894117
[TBL] [Abstract][Full Text] [Related]
16. [Specialised first-episode psychosis services: a systematic review of the literature].
Skalli L; Nicole L
Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
[TBL] [Abstract][Full Text] [Related]
17. A community intervention for early identification of first episode psychosis: impact on duration of untreated psychosis (DUP) and patient characteristics.
Malla A; Norman R; Scholten D; Manchanda R; McLean T
Soc Psychiatry Psychiatr Epidemiol; 2005 May; 40(5):337-44. PubMed ID: 15902403
[TBL] [Abstract][Full Text] [Related]
18. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
Vacheron MN; Veyrat-Masson H; Wehbe E
Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
[TBL] [Abstract][Full Text] [Related]
19. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
[TBL] [Abstract][Full Text] [Related]
20. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
